Pharma Reviews
Pages
Home
Pharma News
US FDA News
Pharma Jobs
Friday, August 17, 2018
US FDA News: FDA permits marketing of transcranial magnetic stimulation for treatment of obsessive compulsive disorder
FDA permits marketing of transcranial magnetic stimulation for treatment of obsessive compulsive disorder
Read more:
FDA permits marketing of transcranial magnetic stimulation for treatment of obsessive compulsive disorder
Newer Post
Older Post
Home
View mobile version